Logo image of ROI

RISKON INTERNATIONAL INC (ROI) Stock Fundamental Analysis

NASDAQ:ROI - Nasdaq - US27888N4060 - Common Stock - Currency: USD

0.1218  +0 (+3.57%)

After market: 0.1159 -0.01 (-4.84%)

Fundamental Rating

0

Overall ROI gets a fundamental rating of 0 out of 10. We evaluated ROI against 212 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of ROI have multiple concerns. ROI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ROI had negative earnings in the past year.
In the past year ROI has reported a negative cash flow from operations.
In the past 5 years ROI always reported negative net income.
ROI had a negative operating cash flow in each of the past 5 years.
ROI Yearly Net Income VS EBIT VS OCF VS FCFROI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

ROI has a Return On Assets of -340.15%. This is amonst the worse of the industry: ROI underperforms 99.53% of its industry peers.
Industry RankSector Rank
ROA -340.15%
ROE N/A
ROIC N/A
ROA(3y)-143.33%
ROA(5y)-203.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROI Yearly ROA, ROE, ROICROI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ROI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ROI Yearly Profit, Operating, Gross MarginsROI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K -50K

0

2. Health

2.1 Basic Checks

ROI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ROI has been increased compared to 1 year ago.
ROI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ROI has a worse debt to assets ratio.
ROI Yearly Shares OutstandingROI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
ROI Yearly Total Debt VS Total AssetsROI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -26.69, we must say that ROI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ROI (-26.69) is worse than 77.10% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -26.69
ROIC/WACCN/A
WACC6.2%
ROI Yearly LT Debt VS Equity VS FCFROI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

2.3 Liquidity

ROI has a Current Ratio of 0.29. This is a bad value and indicates that ROI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ROI (0.29) is worse than 94.86% of its industry peers.
ROI has a Quick Ratio of 0.29. This is a bad value and indicates that ROI is not financially healthy enough and could expect problems in meeting its short term obligations.
ROI has a worse Quick ratio (0.29) than 93.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.29
Quick Ratio 0.29
ROI Yearly Current Assets VS Current LiabilitesROI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.75% over the past year.
Looking at the last year, ROI shows a very strong growth in Revenue. The Revenue has grown by 130.67%.
EPS 1Y (TTM)1.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.27%
Revenue 1Y (TTM)130.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ROI Yearly Revenue VS EstimatesROI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M

0

4. Valuation

4.1 Price/Earnings Ratio

ROI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ROI Price Earnings VS Forward Price EarningsROI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ROI Per share dataROI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ROI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RISKON INTERNATIONAL INC

NASDAQ:ROI (2/27/2024, 8:00:03 PM)

After market: 0.1159 -0.01 (-4.84%)

0.1218

+0 (+3.57%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-20 2024-02-20/amc
Earnings (Next)07-13 2024-07-13/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change57.14%
Market Cap3.97M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 57.43
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-44.26
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS0
BVpS-0.41
TBVpS-0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -340.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-143.33%
ROA(5y)-203.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.29
Quick Ratio 0.29
Altman-Z -26.69
F-Score3
WACC6.2%
ROIC/WACCN/A
Cap/Depr(3y)937.12%
Cap/Depr(5y)564%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)130.67%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y15.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.37%
OCF growth 3YN/A
OCF growth 5YN/A